GSK3B and depressive disorder: This data suggests that the inhibitory effect of ketamine on circadian function involves GSK3β, a kinase that has been already implicated in the regulation of various circadian proteins [54]–[58] and which has been linked to the regulation of depressive disorders [59], [60].